Evoke Pharma (EVOK) Current Leases (2020 - 2025)
Historic Current Leases for Evoke Pharma (EVOK) over the last 6 years, with Q3 2025 value amounting to $65968.0.
- Evoke Pharma's Current Leases changed N/A to $65968.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $65968.0, marking a year-over-year change of. This contributed to the annual value of $59533.0 for FY2024, which is N/A changed from last year.
- Per Evoke Pharma's latest filing, its Current Leases stood at $65968.0 for Q3 2025.
- Evoke Pharma's Current Leases' 5-year high stood at $140300.0 during Q3 2022, with a 5-year trough of $12428.0 in Q4 2021.
- Over the past 5 years, Evoke Pharma's median Current Leases value was $63769.0 (recorded in 2025), while the average stood at $72637.1.
- In the last 5 years, Evoke Pharma's Current Leases crashed by 9122.97% in 2021 and then soared by 93857.42% in 2022.
- Over the past 5 years, Evoke Pharma's Current Leases (Quarter) stood at $12428.0 in 2021, then skyrocketed by 938.57% to $129074.0 in 2022, then crashed by 89.64% to $13370.0 in 2023, then soared by 345.27% to $59533.0 in 2024, then increased by 10.81% to $65968.0 in 2025.
- Its Current Leases stands at $65968.0 for Q3 2025, versus $63769.0 for Q2 2025 and $61625.0 for Q1 2025.